Gland Pharma Limited
403words
3turns
0analyst exchanges
0executives
Key numbers — 1 extracted
rs
25
Speaking time
1
1
1
Opening remarks
Investor Meetings with the Company
Date Date Investor/Analyst/Fund Name Investor/Analyst/Fund Name Type of Meeting Type of Meeting Carnelian Asset Management Carnelian Asset Management One-on-One Meeting One-on-One Meeting 360 ONE Capital (B&K) Investor Conference 360 ONE Capital (B&K) Investor Conference One-on-One & One-on-One & Group Meetings Group Meetings Ashmore Investment Management Ashmore Investment Management One-on-One Meeting One-on-One Meeting The schedule of the above-mentioned meetings is subject to change, and the change may occur due to The schedule of the above-mentioned meetings is subject to change, and the change may occur due to exigencies on the part of the Investor/ Analyst/ Company. exigencies on the part of the Investor/ Analyst/ Company. This is for your information and records. This is for your information and records. Yours truly, Yours truly, For Gland Pharma Limited For Gland Pharma Limited Sampath Kumar Pallerlamudi Sampath Kumar Pallerlamudi Company Secretary & Compliance Officer Company
Regd. Office
Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘X’ Roads D.P. Pally, Dundigal, Dundigal-Gandimaisamma Mandal Medchal-Malkajgiri District, Hyderabad 500043,Telangana, India Tel: +91-40-30510999 Fax: +91-40-30510800
Corporate Office
Plot No. 11 & 84, TSIIC Phase: IV Pashamylaram (V), Patancheru (M), Sangareddy District Hyderabad 502307, Telangana, India Tel: +91-8455-699999 CIN: L24239TG1978PLC002276 | email: gland@glandpharma.com; investors@glandpharma.com | www.glandpharma.com